Posted by Michael Wonder on 09 Aug 2024
Canada’s Drug Agency taking steps to expand access to real world evidence
7 August 2024 - Canada’s Drug Agency has published a summary report from its time-limited Industry Task Force.
The report outlines key actions for the organisation, and the broader health care community, that can enable the use of industry-sponsored real world evidence to help improve our understanding of the safety and effectiveness of new treatments.
The time-limited task force represents a first of its kind collaboration between the pharmaceutical industry, Canada’s Drug Agency, and Health Canada.
